Citadel Advisors’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Buy	153,739 +8,650	+6%	+$13.1K	﹤0.01%	4875
2025 Q1	$435K	Buy	145,089 +41,454	+40%	+$124K	﹤0.01%	4107
2024 Q4	$992K	Hold	103,635	–	–	﹤0.01%	3263
2024 Q3	$1.52M	Buy	+103,635	New	+$1.52M	﹤0.01%	2733